Service Platform
Related Services and Solutions
We look forward to working with you and providing you with excellent service.
Product Series
Chemical Intermediates List
|
NO. |
Product Name |
Structure |
Status |
|
101 |
Carbamazepine intermediates |
||
|
101-1 |
Iminodibenzyl Iminodibenzyl (IDB) CAS: 494-19-9 |
|
Commercial |
|
101-2 |
Iminostilbene Carbonyl Chloride Iminosulfonyl Chloride (ISBCC) CAS:33948-22-0 |
|
Commercial |
|
102 |
Carbamazepine Bromine-Free Intermediates – Bromine-Free Carbamazepine Intermediates |
||
|
102-1 |
Iminostilbene Iminospirobiindane (ISB) CAS:256-96-2 |
|
Commercial |
|
103 |
Oxcarbazepine intermediates |
||
|
103-1 |
10-Methoxy Iminostilbene 10-Methoxyimino stilbene (10-MISB) CAS:4698-11-7 |
|
Commercial |
|
104 |
Paroxetine intermediates |
||
|
104-1 |
(3S,4R)-3-(3,4-Methylenedioxyphenoxy-methyl)-4- (4'-Fluorophenyl)-N-methylpiperidine N-Methylparoxetine CAS:110429-36-2 |
|
Commercial |
|
105 |
Venlafaxine intermediates |
||
|
105-1 |
1-(4-Methoxyphenyl)-2-Aminoethyl Cyclohexanol Hydrochloride 1-(4-Methoxyphenyl)-2-aminoethylcyclohexanol hydrochloride CAS:130198-05-9 |
|
Commercial |
|
201 |
Ketoprofen intermediates |
||
|
201-1 |
2-(3-Benzoylphenyl)Propionitrile Isopropylidenediphenylketone CAS: 42872-30-0 |
|
Commercial |
|
NO. |
Product Name |
Structure |
Status |
|
301 |
Gliclazide intermediates |
||
|
301-1 |
N-Amino-Aza-3-Bicyclo[3,3,0]Octane Hydrochloride N-Amino-azepane-3-spiro[3,3]octane hydrochloride CAS:58108-05-7 |
|
Commercial |
|
401 |
Cabapenem intermediates |
||
|
401-1 |
(3R,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)] ethyl]azetidin-2-one AOSA (4-AA) 4-Acetoxyazetidin-2-one CAS: 76855-69-1 |
|
Commercial |
|
401-2 |
Thienamycin p-nitrobenzyl ester hydrochloride (N-methylpyrrolidinone solvate) Thiomyicin nitrobenzoate hydrochloride (N-methylpyrrolidone solvent compound) CAS: 442847-66-7 |
|
Commercial |
|
402 |
Meropenem intermediates |
||
|
402-1 |
P-Nitrobenzyl (1R,5R,6S)-6-[(1R)-1-hydroxyethyl]-2-[(diphenylphosphonooxy)]-1-methylcarbapen-2-em-3-carboxylate MAP [4R-[4a,5b,6b(R*)]]-3-Diphenylphosphoryloxy-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid p-nitrobenzyl ester CAS: 90776-59-3 |
|
Commercial |
|
402-2 |
(R)-4-Nitrobenzyl-2-diazo-4-((2R,3S)-3-((R)-1-hydroxyethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate (3S,4R)-4-[(1R)-1-Hydroxyethyl]-3-[(1R)-1-Methyl-3-diazo-3-p-nitrobenzylcarbonyl-2-oxo] (Meropenem Intermediate F9) CAS:137391-68-5 |
|
Commercial |
|
402-3 |
(2S,4S)-2-[(Dimethylamino)carbonyl]-4-mercapto-1-pyrrolidinecarboxylic acid-(4'-nitrophenyl)methyl ester (2S,4S)-2-[(Dimethylcarbamoyl)-4-mercapto-1-pyrrolidinecarboxylic acid (4'-nitro)benzyl ester CAS: 96034-64-9 |
|
Commercial |
|
NO. |
Product Name |
Structure |
Status |
|
501 |
Sitagliptin intermediates |
||
|
501-1 |
Boc-(R)-3-Amino-4-(2,4,5-trifluoromethyl)butyrate Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butyric acid CAS: 486460-00-8 |
|
Commercial |
|
501-2 |
2,4,5-Trifluorophenylacetic acid 2,4,5-Trifluorophenylacetic acid CAS: 209995-38-0 |
|
Commercial |
|
501-3 |
3-Trifluoromethyl-[1,2,4]triazolo[4,3-a]piperazine hydrochloride 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride CAS: 762240-92-6 |
|
Commercial |
|
501-4 |
(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one Sitagliptin Base (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one Sitagliptin monomer CAS: 486460-32-6 |
|
Commercial |
|
501-5 |
4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-1-one CAS: 764667-65-4 |
|
Commercial |
|
601 |
Sulfasalazine intermediates |
||
|
601-1 |
Sulfapyridine Sulfapyridine CAS: 144-83-2 |
|
Commercial |
|
701 |
Imatinib intermediates |
||
|
701-1 |
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS:106261-49-8 |
|
Commercial |
|
701-2 |
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-aminopyrimidine CAS:152460-10-1 |
|
Commercial |
|
NO. |
Product Name |
Structure |
Status |
|
801 |
Relebactam intermediates |
||
|
801-1 |
(2S,5S)-5-hydroxypiperidine-2-carboxylic acid (2S,5S)-5-Hydroxypiperidine-2-carboxylic acid CAS:63088-78-8 |
|
Commercial |
|
801-2 |
tert-butyl 4-((1R,2S,5R)-6-hydroxy-7-oxo-1,6-diazabicyclo[3.2.1]) octane-2-carboxamido) piperidine-1-carboxylate 4-[[[(1R,2S,5R)-6-Hydroxy-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-yl]carbonyl]amino]-1-piperidinecarboxylic acid tert-butyl ester CAS:1174020-64-4 |
|
Commercial |
|
901 |
Avibactam intermediates |
||
|
901-1 |
(2S,5R)-5-((4-methoxybenzyl)oxy)amino)piperidine-2-carboxamide |
|
Commercial |
|
901-2 |
(2S,5R)-6-((4-methoxybenzyl)oxy)-7-oxo-1,6-diazabicyclo [3.2.1]octane-2-carboxamide |
|
Commercial |
|
901-3 |
tetrabutylammonium (2S,5R)-2-carbamoyl- 7-Oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate (tetrabutylammonium) salt CAS: 1192651-80-1 |
|
Commercial |
|
1001 |
Cilastatin intermediates |
||
|
1001-1 |
(S,Z)-7-chloro-2-(1,2,2-trimethylcyclopropane-1- Carboxamido)hept-2-enoic acid 7-Chloro-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic acid CAS: 877674-77-6 |
|
Commercial |
|
NO. |
Product Name |
Structure |
Status |
|
1101 |
Semaglutide intermediates |
||
|
1101-1 |
Fmoc-Glu(OtBu)-Gly-OH (FMC) (S)-2-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoylamino)acetic acid Semaglutide Intermediate (TTA-A20) CAS: 866044-63-5 |
|
Commercial |
|
1101-2 |
Fmoc-Lys(AEEA-AEEA-g-Glu(OtBu)-Oct(OtBu))-OH Semaglutide Intermediate (MAT) CAS:1662688-20-1 |
|
Commercial |
|
1101-3 |
Fmoc-Gly-Arg(Pbf)-OH Semaglutide Intermediate (FMC) CAS: L1048377-78-1 |
|
Commercial |
|
1101-4 |
Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH Semaglutide Intermediate (TTA) CAS:1890228-73-5 |
|
Commercial |
|
1101-5 |
tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu Semaglutide intermediate (side chain) CAS: 1118767-16-0
|
|
Commercial |
|
1101-6 |
Glycine, L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl- L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycylChemicalbook L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl- L-Tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-(parent ring) Semaglutide Intermediate (P29) CAS 1169630-82-3 |
|
Commercial |
|
NO. |
Product Name |
Structure |
Status |
|
1201 |
Sacubitril intermediates |
||
|
1201-1 |
tert-Butyl (R)-(1-([1,1'-biphenyl]-4-yl)-3-hydroxypropane (2-yl)carbamate LCZ696 intermediate CAS:1426129-50-1 |
|
Commercial |
|
1201-2 |
(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl) amino)-2-methylpent-2-enoic acid (R,E)-5-([1,1'-Biphenyl]-4-yl)-4-[(tert-Butoxycarbonyl)amino]-2 -Methyl-2-pentenoic acid CAS:1012341-48-8 |
|
Commercial |
|
1201-3 |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl) amino)-2-methylpentanoic acid (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-Butoxycarbonyl)amino]-2-methylpentanoic acid CAS:1012341-50-2 |
|
Commercial |
|
1201-4 |
(2R,4S)-4-Amino-5-(biphenyl-4-yl)-2-methylpentanoic Acid Ethyl Ester Hydrochloride (2R,4S)-4-Amino-5-(biphenyl-4-yl)-2-methylpentanoic acid ethyl ester hydrochloride CAS:149690-12-0 |
|
Commercial |
|
1301 |
Dapagliflozin intermediates |
||
|
1301-1 |
(2R,3R,4R,5S,6S)-2-(acetoxy)methyl-6-(4-chloro-3- (4-Ethoxybenzyl)phenyltetrahydro-2H-pyran-3,4,5-triyl triacetate (2R,3R,4R,5S,6S)-2-(Acetyloxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl) Phenyl)tetrahydro-2H-pyran-3,4,5-triacetate CAS:461432-25-7 |
|
Commercial |
|
1401 |
Edoxaban intermediates |
||
|
1401-1 |
tert-butyl ((1R,2S,5S)-2-amino-5- (Dimethylcarbamoyl)cyclohexyl carbamate [(1R,2S,5S)-2-Amino-5-[(dimethylamino)carbonyl]...; 5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl] tert-butyl carbamate CAS: 365998-36-3 |
|
Commercial |
|
1401-2 |
5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid Edoxaban intermediate CAS: 720720-96-7 |
|
Commercial |
|
NO. |
Product Name |
Structure |
Status |
|
1501 |
Rimegepant Sulfate Intermediates – Rimegepant Sulfate Intermediates |
||
|
1501-1 |
(5S,6S,9R)-6-(2,3-Difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-amine dihydrochloride (5S,6S,9R)-6-(2,3-Difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-amine hydrochloride CAS: 1373116-04-1 |
|
Pilot Phase |
|
1501-2 |
(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohept[b]pyridin-9-ol CAS: 1373116-05-2 |
|
Pilot Phase |
|
1501-3 |
(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol: dihydrochloride (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohept[b]pyridin-9-ol dihydrochloride CAS: 1373116-07-4 |
|
Pilot Phase |
|
1501-4 |
1-(1-(1H-imidazole-1-carbonyl)piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one 1-(1-(1H-imidazol-1-yl-ethoxycarbonyl)pyridin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one CAS: 1373116-06-3 |
|
Pilot Phase |
|
NO. |
Product Name |
Structure |
Status |
|
1601 |
Olmesartan Medoxomil Intermediates |
||
|
1601-1 |
Ethyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylate CAS: 144689-93-0 |
|
Commercial |
|
1601-2 |
Trityl olmesartan medoxomil Triphenylmethyl olmesartan CAS: 144690-92-6 |
|
Commercial |













































